Education
About Us
Working with TipRanks
Follow Us
Elazer R Edelman Insider Profile
11 Followers
Elazer R Edelman, Director at Echo Therapeutics, holds 0.00 shares in Echo Therapeutics (Ticker: ECTE), holds 367.45K shares in Butterfly Network (Ticker: BFLY). Most recently, Elazer R Edelman ― shares of Echo Therapeutics on ― for an estimated value of ―.
Elazer R Edelman Echo Therapeutics (ECTE)Director
Echo Therapeutics (ECTE)
Director
Not Ranked
Elazer R Edelman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Elazer R Edelman's holdings
Insider Roles
Director
Roles that Elazer R Edelman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Elazer R Edelman
Elazer R Edelman's Trading History
Echo Therapeutics
―
―
―
$0.00
Butterfly Network
Jun 17, 2025
Director
Uninformative Buy
―
$712.85K
List of latest transactions for each holding click on a transaction to see Elazer R Edelman's performance on stock
You May Also Like
Elazer R Edelman insider profile FAQ
What is the percentage of profitable transactions made by Elazer R Edelman?
The percentage of profitable transactions made by Elazer R Edelman is ―.
What is the average return per transaction made by Elazer R Edelman?
The average return per transaction made by Elazer R Edelman is ―.
What stocks does Elazer R Edelman hold?
Elazer R Edelman holds: ECTE, BFLY stocks.
What was Elazer R Edelman’s latest transaction?
Elazer R Edelman latest transaction was an Uninformative Buy of ―.
What was Elazer R Edelman's most profitable transaction?
Elazer R Edelman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Elazer R Edelman's role in Echo Therapeutics?
Elazer R Edelman's role in Echo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.